DCF — SMDC MEDICAL CENTER
Enterprise Value: $-610.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-610.2M
Enterprise Value
$-198.2M
PV of Cash Flows
$-412.0M
PV of Terminal Value
$-663.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $534.8M | $-35.2M | -7.0% | $-57.8M | $-52.6M |
| Year 2 | $550.8M | $-30.8M | -6.0% | $-54.1M | $-44.7M |
| Year 3 | $567.4M | $-26.0M | -5.0% | $-50.0M | $-37.6M |
| Year 4 | $584.4M | $-23.9M | -4.0% | $-48.6M | $-33.2M |
| Year 5 | $601.9M | $-23.1M | -4.0% | $-48.6M | $-30.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-610.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$519.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.07083367761583967
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5